AXT Inc (AXTI) Q4 2024 Earnings Call Highlights: Revenue Growth Amidst Margin Challenges

GuruFocus.com
21 Feb
  • Revenue (Q4 2024): $25.1 million, up from $23.6 million in Q3 2024 and $20.4 million in Q4 2023.
  • Indium Phosphide Revenue (Q4 2024): $9.1 million.
  • Gallium Arsenide Revenue (Q4 2024): $5.4 million.
  • Germanium Substrates Revenue (Q4 2024): $1.6 million.
  • Raw Material Joint Venture Revenue (Q4 2024): $9.0 million.
  • Non-GAAP Gross Margin (Q4 2024): 17.9%, down from 24.3% in Q3 2024 and 23.2% in Q4 2023.
  • GAAP Gross Margin (Q4 2024): 17.6%, down from 24.0% in Q3 2024 and 22.6% in Q4 2023.
  • Non-GAAP Operating Expense (Q4 2024): $9.9 million, up from $9.0 million in Q3 2024 and $7.5 million in Q4 2023.
  • GAAP Operating Expense (Q4 2024): $10.6 million, up from $9.1 million in Q3 2024 and $8.2 million in Q4 2023.
  • Non-GAAP Operating Loss (Q4 2024): $5.4 million, compared to $2.6 million in Q3 2024 and $2.7 million in Q4 2023.
  • GAAP Operating Loss (Q4 2024): $6.2 million, compared to $3.4 million in Q3 2024 and $3.6 million in Q4 2023.
  • Non-GAAP Net Loss (Q4 2024): $4.3 million or $0.10 per share.
  • GAAP Net Loss (Q4 2024): $5.1 million or $0.12 per share.
  • Cash, Cash Equivalents, and Investments (Dec 31, 2024): $33.8 million, down from $38.8 million on Sep 30, 2024.
  • Fiscal Year 2024 Revenue: $99.4 million, up 31% from $75.8 million in fiscal year 2023.
  • Non-GAAP Gross Margin (Fiscal Year 2024): 24.3%, up from 18.1% in fiscal year 2023.
  • GAAP Gross Margin (Fiscal Year 2024): 24%, up from 17.6% in fiscal year 2023.
  • Non-GAAP Net Loss (Fiscal Year 2024): $8.5 million or $0.20 per share, improved from $14.3 million or $0.34 per share in fiscal year 2023.
  • GAAP Net Loss (Fiscal Year 2024): $11.6 million or $0.27 per share, improved from $17.9 million or $0.42 per share in fiscal year 2023.
  • Warning! GuruFocus has detected 5 Warning Signs with AXTI.

Release Date: February 20, 2025

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

  • AXT Inc (NASDAQ:AXTI) reported a 31% increase in fiscal year 2024 revenue, reaching $99.4 million, up from $75.8 million in fiscal year 2023.
  • The company achieved a 6% improvement in non-GAAP gross margin for fiscal year 2024, rising to 24.3% from 18.1% in 2023.
  • AXT Inc (NASDAQ:AXTI) successfully penetrated the wireless handset market, particularly in China, and expanded its portfolio of raw material companies.
  • The company introduced 8-inch gallium arsenide and 6-inch indium phosphide substrates, enhancing its development capabilities.
  • AXT Inc (NASDAQ:AXTI) is seeing growth opportunities in cloud and data center connectivity, driven by high-speed optical interconnects and AI adoption.

Negative Points

  • The company's Q4 2024 gross margin and net loss fell short of expectations, with a non-GAAP operating loss of $5.4 million.
  • AXT Inc (NASDAQ:AXTI) experienced a decline in gross margin due to lower benefits from its recycling program and under-absorption of manufacturing overhead.
  • The company faces challenges from new trade restrictions imposed by the Chinese government on the export of indium phosphide material.
  • AXT Inc (NASDAQ:AXTI) expects a revenue impact of approximately $4 million to $5 million in Q1 2025 due to delayed indium phosphide sales.
  • The company's cash, cash equivalents, and investments decreased by $5.0 million to $33.8 million as of December 31, 2024.

Q & A Highlights

Q: Can you explain the factors behind the lower gross margins and increased operating expenses in Q4, and how long these trends might continue? A: Gary Fischer, CFO, explained that gross margins are expected to remain low in Q1 due to reduced indium phosphide sales from export restrictions. However, they anticipate margins to return to mid-20% levels post-Q1. Morris Young, CEO, added that R&D investments in indium phosphide and gallium arsenide are nearing completion, which should improve yields and performance.

Q: What opportunities do you see for indium phosphide in data centers, and what is the revenue outlook for 2026? A: Tim Bettles, VP of Business Development, noted growth in both photodetectors and lasers, with a significant opportunity in high-speed VCSELs and indium phosphide-based photodetectors. They expect continued growth in 2025, with new opportunities in low EPD ion diode materials for next-generation EML lasers.

Q: How do you anticipate the impact of China's indium phosphide export restrictions, and what is your experience with similar gallium arsenide restrictions? A: Tim Bettles stated that the restrictions aim to prevent military applications, and they expect to secure permits for non-military uses. Based on past experience with gallium arsenide, they are optimistic about obtaining necessary permits without significant issues.

Q: Can you provide insights into the wireless market opportunity and expected growth in 2025? A: Morris Young highlighted that AXT has grown its market share in the HBT market from zero to 10% and aims to increase it by 30% in 2025. They plan to leverage process improvements from their 8-inch experience to enhance competitiveness and market share.

Q: What is the expected growth for indium phosphide in 2025, excluding export restrictions? A: Tim Bettles projected a 20% year-over-year growth, driven by increased adoption of silicon photonics and EML technologies. The market is dynamic, and additional growth could occur as these technologies gain traction.

Q: How do you plan to manage the germanium business given current market conditions? A: Morris Young explained that while demand is strong, high raw material costs limit profitability. They plan to manage market entry based on raw material price levels to ensure profitability.

Q: What is the mix between photodetectors and silicon photonics in your indium phosphide business? A: Tim Bettles indicated a 60/40 or 65/35 split in favor of lasers over detectors, with significant growth potential in both areas, particularly in silicon photonics.

Q: How do you expect the indium phosphide business to recover from export restrictions compared to gallium arsenide? A: Morris Young believes indium phosphide will recover more robustly due to its critical role and established customer relationships. They anticipate a strong recovery once permits are secured.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

This article first appeared on GuruFocus.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10